April 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJuly 30, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreApril 21, 2026
According to market projections, the theranostics sector is expected to grow from USD 2.42 billion in 2024 to USD 10.21 billion by 2034, reflecting a CAGR of 15.46%. Technological advancements and boosting non-oncological applications are driving the global market expansion. North America led with its rising cancer cases and healthcare system....
April 21, 2026
Market insights predict, the infectious disease diagnostics industry is expected to grow from USD 25.01 billion in 2024 to USD 62.95 billion by 2034, driven by a CAGR of 9.67%.The market is growing due to healthcare providers seeking faster, more reliable detection methods to control outbreaks. Growing awareness, government initiatives, and technol...
April 21, 2026
Based on market forecasts, the global syphilis testing market, projected at USD 2.29 billion in 2024, is expected to reach USD 4.57 billion by 2034, growing at a CAGR of 6.85% over the forecast period. The market is expanding due to the global increase in syphilis cases and other sexually transmitted infections. Growth is further fueled by rising a...
April 21, 2026
Projections indicate that, the global preimplantation genetics diagnosis (PGD) market will increase from USD 67.79 million in 2024 to USD 144.19 million by 2034, experiencing a CAGR of 7.84% over the next 10 years. The preimplantation genetics diagnosis (PGD) market is expanding due to growing advancements as well as increasing IVF usage. North Ame...
April 21, 2026
Market insights predict, the diagnostic testing industry is expected to grow from USD 203.3 billion in 2024 to USD 274.53 billion by 2034, driven by a CAGR of 3.04%. The rising prevalence of chronic and infectious diseases is estimated to drive the growth of the market. North America led the global market owing to its advanced healthcare infrastruc...
April 21, 2026
Projections indicate that, the global pathology laboratories market will increase from USD 380.95 billion in 2024 to USD 834.44 billion by 2034, experiencing a CAGR of 8.2% over the next 10 years. The market is growing due to the rising demand for early disease diagnosis and advanced diagnostic testing. North America leads the market due to technol...
April 21, 2026
According to market projections, the U.S. point-of-care infectious disease testing market, valued at USD 2.1 billion in 2024, is anticipated to reach USD 5.01 billion by 2034, growing at a CAGR of 9.34% over the next decade. The expanding growth of point-of-care testing for infectious diseases in the U.S. is driven by improved patient outcomes, inc...
April 21, 2026
The dental panoramic X-ray market is growing because it is utilized when checking for jaw disorders, wisdom teeth, and issues involving sinuses and oral health. North America is dominant in the market due to its high consumer spending on dental care and huge adoption of advanced modern imaging technologies....
April 21, 2026
The IVD diagnostic molecule raw enzymes market is valued at USD 2.39 billion in 2024, projected to reach USD 4.73 billion by 2034 at a 7.13% CAGR. It includes segmentation by enzyme type, application, and technology, with leading regions like North America (45.9%) and Asia Pacific. The study covers trade data, supply chain, key players like QIAGEN,...
April 02, 2026
Blood-Based Biomarker for Alzheimer’s Disease Diagnostics Market (By Biomarker Type: Amyloid-Based Biomarkers, Tau-Based Biomarkers, Neurodegeneration Biomarkers, Inflammatory Biomarkers, Other Emerging Biomarkers; By Technology Platform: Immunoassays, Mass Spectrometry, PCR-Based Assays, Next-Generation Sequencing, Biosensor-Based Platforms;...
+1 804 441 9344
+65 3106 5601 or +91 87933 22019
